MedPath

Serc

Brand Name: Serc

Generic Name: Betahistine Hydrochloride

Active
Registration Number

DRP-472

Dosage Form

Tablet

Issuance Date

March 1, 2024

Expiry Date

April 15, 2029

Product Information

Philippine FDA product specifications and classification details

Product Specifications

Dosage Strength8mg
PackagingBlister pack of 25's (Box of 100's)

Classification

C
Classification
Prescription Drug (RX)
P
Pharmacologic
Anti-vertigo
A
Application
Renewal
Philippine FDA Classification

Active Ingredients (1)

Complete list of active ingredients in this pharmaceutical product.

Betahistine HydrochlorideActive
Monograph: Betahistine

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

MedPath - Medical Intelligence Platform